Traditional medical treatment versus interventional approach in acute iliofemoral vein thrombosis

Phase 3

• Conditions: Acute liofemoral veins thrombosis.; other venous embolism and thrombosis

• Registration Number: IRCT201108035625N3
• Lead Sponsor: Vice Chancellor for research,Tehran Heart Center (TUMS)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Consecutive patients with acute extensive iliofemoral venous thrombosis will be included.
Exclusion criteria: previous history of allergy to thrombolytic or contrast agents; anticoagulation contrandications; bleeding disorders, active internal bleeding, recent gastrointestinal bleeding, recent cerebrovascular accident, recent major surgery (<10 days), recent serious trauma, severe hypertension, pregnancy or recent delivery, metastatic malignancy with central nervous system involvement, chronic iliofemoral venous thrombosis (more than 14 days from incidence);patients with survival of less than 1 year; severe renal failure (GFR<30); history of subarachnoid hemorrhage (SAH) or intra cranial hemorrhage (ICH)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Venous patency. Timepoint: One, six and twelve months follow up. Method of measurement: Doppler ultra sonography and MDCT venography.

Secondary Outcome Measures

Name	Time	Method
Symptom changes (pain,edema,varices,...). Timepoint: One, six and twelve months follow up. Method of measurement: Clinical evaluation.